Investment company I Love Lund expects a "clearly positive" financial impact from Swiss pharmaceutical giant Roche’s purchase of Swedish-founded Saga Diagnostics for $595 million, according to a press release.I Love Lund is a co-owner of Saga Diagnostics after taking part in a financing round in 2021. In total, it has invested just over $115,000, equivalent to SEK 1.1 million, and as of today holds 198,649 shares in the form of Series A preferred stock.While I Love Lund expects a positive effect from the deal, it is currently not able to detail the possible size or scope."The holding is today not recorded as one of I Love Lund’s most significant holdings, but the expected purchase price may still have a good positive impact on our results during the year," the company ?????.